NIH-funded research R01 grant

Investigating genetic factors that contribute to glaucoma risk and progression

Official title: Genetic Factors for Glaucoma in the OHTS; Risk, Progression and Mechanism

Funded at University of Iowa · NIH-11030825 · Data updated 2026-11-12

This study is looking at how our genes can influence the risk of developing primary open angle glaucoma, a common cause of vision loss, and aims to create a helpful tool for patients and doctors to understand that risk better and track the disease's progress.

More Glaucoma research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startSeptember 30, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$400,478
NIH project number5R01EY035266-03
Project IDNIH-11030825 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for primary open angle glaucoma, particularly those with a family history of the disease or elevated intraocular pressure.

Less likely to help

Patients with other forms of glaucoma or those who do not have a genetic predisposition to POAG may not benefit from this research.

What this research studies

This research focuses on understanding the genetic factors that contribute to primary open angle glaucoma (POAG), a leading cause of vision loss. By analyzing data from previous genome-wide association studies and utilizing 20 years of clinical data from the Ocular Hypertension Treatment Study, the researchers aim to develop a risk calculator that combines both genetic and clinical factors. This tool will help patients and their healthcare providers assess the risk of developing glaucoma and its progression. Additionally, the study will explore how specific genetic variations affect the progression of the disease through advanced techniques like single-cell RNA sequencing.

Why it matters

Potential benefit: If successful, this research could lead to personalized glaucoma management strategies that improve patient outcomes and preserve vision.

How similar studies have gone: Previous research has successfully identified genetic risk factors for glaucoma, making this approach a continuation of established findings rather than a completely novel endeavor.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Fingert, John H — University of Iowa
  • Study coordinator: Fingert, John H

Related research

Other NIH-funded projects on the same topics.

  • IOP and CSF Pressure in Glaucoma Risk

    This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.

    NIH research University of Alabama at Birmingham · Birmingham, United States · NIH-11644421

  • Comparing tube positions in glaucoma implants to protect corneal cells

    This trial compares two tube placements for glaucoma drainage implants to see which better protects corneal cells and controls eye pressure in people with uncontrolled glaucoma.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11520347

  • Automated topographic test for glaucoma detection and progression

    A new automated method uses topographic structure-function mapping to help diagnose glaucoma earlier and track its progression in patients.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11516608

  • Using AI on eye scans and genes to predict glaucoma risk

    This project uses artificial intelligence on eye scans, vision tests, and genetic information to find people most likely to develop or have worsening glaucoma.

    NIH research University of Miami School of Medicine · Coral Gables, United States · NIH-11469603

  • AI-based glaucoma screening in community health centers

    A new, easy-to-use AI screening approach will be tested in federally funded health centers to help identify people at risk for glaucoma, especially in communities with higher risk.

    NIH research University of Alabama at Birmingham · Birmingham, United States · NIH-11454104

  • Understanding how glaucoma genes control eye cell function

    A long-term research project will study how genetic factors affect eye cells in adults with glaucoma to uncover new ideas for protecting vision.

    NIH research Massachusetts Eye and Ear Infirmary · Boston, United States · NIH-11450761

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.